Medical Cannabis in Canada: How a Healthcare Strategist Went From Clinical Trial Enrolment To Cannabis — and Why He Wants To Improve Our Understanding Of The Treatment Category

Article by Max Monahan-Ellison, Growth Op

WellnessMedicalInnovationHealthExpertsConcentratesCBD Medical Cannabis in Canada: How a healthcare strategist went from clinical trial enrolment to cannabis — and why he wants to improve our understanding of the treatment category This story is a part of Medical Cannabis in Canada, a new column that takes a deep dive into the sector from the perspectives of patients, healthcare professionals, policymakers, researchers and professionals that navigate it. Author of the article:The GrowthOp In Health Canada’s 2020 Canadian Cannabis Survey (CCS), released last month, 14 per cent of Canadians aged 16 years and older indicated that they used cannabis for medical purposes, but medical cannabis is at a crossroads in Canada. PHOTO BY MAX MONAHAN-ELLISON Drugs for hemorrhoids — that’s where I started my career.

Drugs for hemorrhoids — that’s where I started my career.

You might wonder what working on a clinical trial enrolment strategy for a rectal medication has to do with medical cannabis, however, it kicked off my passion for tackling misunderstood and stigmatized healthcare challenges that have guided me over the last decade.

Read the full article here.

About Dankr NewsBot

Beep Boop. I'm just a bot who brings you the dankest news in the biz

Leave a Reply

Powered by Dragonballsuper Youtube Download animeshow